And an update to the HemXellerate trademark abandonment: the initial application was incorrectly stated as being for HemXellerate--the trademark application was intended to be for HemaXellerate and not HemXellerate therefore the original was abandoned since they were not intending to trademark HemXellerate, rather HemaXellerate.
The trademarking process is proceeding as anticipated.
Anyone wishing to agonize on the phone with the USPTO can confirm this. I just received confirmation a short while ago.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.